N-Nitroso Alprazolam EP Impurity H: Chemical Structure, Characterization, and Analytical Significance

Nitrosamine impurities have become an important consideration in pharmaceutical quality research because their presence in active pharmaceutical ingredients (APIs) and finished drug products may require detailed investigation, sensitive analytical testing, and appropriate risk assessment. Pharmaceutical manufacturers, analytical laboratories, and quality-control (QC) teams must understand the identity of potential impurities and select suitable analytical approaches to investigate them.

N-Nitroso Alprazolam EP Impurity H is a specialized compound relevant to research involving pharmaceutical impurity characterization and analytical method development. Its structural identity, molecular properties, and availability as a reference material are important considerations when designing laboratory investigations.

Chemicea Pharmaceuticals Pvt. Ltd. lists this compound under catalogue number CP-A14018. According to the company's product information, it has the molecular formula C₃₄H₂₆Cl₂N₈O₃ and a molecular weight of 665.54 g/mol. The available certificate of analysis (COA) also reports characterization results from liquid chromatography–mass spectrometry (LC-MS), proton nuclear magnetic resonance (^1H NMR), and high-performance liquid chromatography (HPLC).

This article examines the compound's chemical identity, analytical characterization, role in impurity research, reference-standard considerations, and relevant regulatory principles. It also distinguishes N-Nitroso Alprazolam EP Impurity H from the separately identified Alprazolam EP Impurity H, helping researchers avoid a potentially significant identification error.

1. Understanding N-Nitroso Alprazolam EP Impurity H

The name N-Nitroso Alprazolam EP Impurity H identifies a specific compound associated with nitrosamine-related pharmaceutical impurity research. Although its name includes Alprazolam, its identity should be established using compound-specific structural and analytical information rather than the name alone.

Nitrosamine impurities are generally characterized by a nitrogen-containing structure associated with an N–N=O functional arrangement. Their chemical properties, potential formation pathways, and analytical behavior vary according to their molecular structures. Consequently, findings from one nitrosamine cannot automatically be applied to another.

For analytical researchers, the first step is to establish the correct identity of the material under investigation. This involves reviewing its molecular formula, molecular weight, structural representation, nomenclature, and supporting characterization data.

The European Pharmacopoeia (Ph. Eur.) designation in a product name should also be interpreted carefully. The inclusion of “EP Impurity H” identifies the impurity designation used for the material; it does not, by itself, establish that every supplier's material is an official pharmacopoeial reference standard or that it has been endorsed by a regulatory authority.

Correct identification is essential before a reference material is used for chromatographic comparison, method development, or other pharmaceutical research activities.

2. Chemical Structure and Molecular Properties

The molecular structure provides the foundation for understanding an impurity's identity and analytical behavior. Chemicea's product documentation provides the following information for N-Nitroso Alprazolam EP Impurity H.

Parameter	Product information
Product name	N-Nitroso Alprazolam EP Impurity H
Chemicea catalogue number	CP-A14018
Molecular formula	C₃₄H₂₆Cl₂N₈O₃
Molecular weight	665.54 g/mol
CAS number	Not available (listed as NA)
Reported physical description	Solid
Reported solubility	Soluble in methanol/DMSO

The molecular formula indicates the numbers of carbon, hydrogen, chlorine, nitrogen, and oxygen atoms in the stated molecular composition. The two chlorine atoms and multiple nitrogen-containing groups are relevant structural features when evaluating possible mass-spectrometric signals and interpreting spectroscopic data.

The molecular weight is useful when calculating theoretical mass-to-charge ratios for appropriate ion species in mass spectrometry. However, the observed ion depends on the ionization conditions and the type of ion formed. Researchers should not assume that the molecular weight directly corresponds to every measured LC-MS signal.

Similarly, the reported solubility in methanol and dimethyl sulfoxide (DMSO) provides an initial reference for laboratory handling. It does not establish a validated preparation procedure, long-term solution stability, or suitability for every analytical method. Solvent selection and solution preparation should be evaluated against the laboratory's method requirements and the supplier's documentation.

A CAS number is not provided in Chemicea's available COA. Researchers should therefore avoid assigning an unverified CAS number when preparing laboratory records, specifications, or regulatory documentation.

3. Distinguishing N-Nitroso Alprazolam EP Impurity H from Alprazolam EP Impurity H

A critical consideration in pharmaceutical impurity analysis is the difference between compounds with similar names but different chemical structures.

N-Nitroso Alprazolam EP Impurity H and Alprazolam EP Impurity H are distinct chemical entities. The prefix “N-Nitroso” is not merely a naming variation; it identifies a different stated molecular composition.

The reported molecular properties illustrate this distinction.

Characteristic	N-Nitroso Alprazolam EP Impurity H	Alprazolam EP Impurity H
Molecular formula	C₃₄H₂₆Cl₂N₈O₃	C₃₄H₂₇Cl₂N₇O₂
Molecular weight	665.54 g/mol	Approximately 636.54 g/mol
Key distinction	Nitroso-designated compound	Separately identified impurity
Identification approach	Compound-specific characterization	Compound-specific characterization

These differences have practical consequences. Selecting a reference material based only on a partial product name may lead to incorrect peak assignments, unsuitable analytical comparisons, or inaccurate documentation.

Before purchasing or using a reference standard, researchers should verify the complete product name, molecular formula, molecular weight, structural representation, catalogue number, and available certificate of analysis.

4. Analytical Characterization of N-Nitroso Alprazolam EP Impurity H

Analytical characterization helps establish whether a material is consistent with its stated chemical identity and whether it is suitable for a proposed research application. No single analytical technique necessarily provides all the information needed.

Chemicea's available COA for catalogue CP-A14018 reports LC-MS and ^1H NMR results as consistent with the structure, together with HPLC purity greater than 95%. These are supplier-reported results, not a substitute for reviewing the full documentation and determining suitability for a specific analytical procedure.

Liquid chromatography–mass spectrometry (LC-MS)

LC-MS combines chromatographic separation with mass-based detection. It can support impurity identification by separating components and evaluating their mass-to-charge ratios.

For a compound with a molecular weight of 665.54 g/mol, researchers can use the stated molecular composition to evaluate expected ions under suitable ionization conditions. Interpretation should account for the ion species, isotope distribution, adduct formation, and instrument conditions.

LC-MS evidence is strongest when the observed results are evaluated alongside the proposed structure and other characterization data. A statement that a mass spectrum is consistent with a structure should not be interpreted as proof of every aspect of structural identity.

Proton nuclear magnetic resonance (^1H NMR)

Proton NMR provides information about the chemical environments of hydrogen atoms within a molecule. The resulting spectrum can help researchers assess whether the observed signals are consistent with the expected structure.

Interpretation may consider chemical shifts, signal integration, multiplicity, and signal patterns. Solvent, concentration, instrument conditions, and sample composition can influence the spectrum.

For complex molecules, NMR findings are most informative when assessed together with molecular formula and mass-spectrometric evidence.

High-performance liquid chromatography (HPLC)

HPLC is widely used to separate and evaluate components in pharmaceutical samples. Depending on the method and detector, it can support assessments of chromatographic purity, impurity profiles, and relative component abundance.

Chemicea reports HPLC purity of greater than 95% for this material. This figure should be understood in the context of the supplier's reported test. It does not automatically represent a certified mass fraction, absolute assay value, or purity determination under every analytical method.

For quantitative work, laboratories should establish whether the supplied documentation meets their requirements and whether additional characterization or testing is necessary.

5. Role of Reference Standards in Impurity Research

A suitable reference standard can provide a valuable comparison material during analytical method development, impurity identification, and pharmaceutical quality investigations.

For N-Nitroso Alprazolam EP Impurity H, potential research applications may include:

• Analytical method development: Evaluating chromatographic conditions intended to separate the target compound from the API and other components.

• Peak identification: Comparing sample responses with those of an appropriately characterized reference material.

• Method performance evaluation: Investigating selectivity, sensitivity, repeatability, and other relevant performance characteristics.

• Impurity profiling: Supporting investigations into the identity of components detected during pharmaceutical analysis.

• Research and documentation: Providing traceable product information for laboratory records and research workflows.

These are potential applications, not claims that a particular method has been validated using this material.

A reference standard also has limitations. Its suitability depends on identity, purity, characterization, handling, storage, and the intended use. A material supplied for research does not automatically qualify as an official pharmacopoeial reference standard, a certified reference material, or a standard suitable for every regulated quantitative application.

Laboratories should assess the documentation accompanying the material and establish any additional qualification requirements under their quality systems.

6. Regulatory Considerations for Nitrosamine Impurities

Regulatory authorities have issued guidance on the assessment and control of nitrosamine impurities in human medicines. The US Food and Drug Administration (FDA), for example, recommends a risk-based approach involving assessment of potential sources, confirmatory testing when a risk is identified, and appropriate mitigation strategies. Its guidance distinguishes small-molecule nitrosamines from nitrosamine drug substance-related impurities (NDSRIs).

The appropriate classification and risk assessment for an individual compound depend on its chemical identity and the available scientific evidence. The presence of “N-Nitroso” in a product name alone does not establish a compound-specific acceptable intake limit, carcinogenic potency category, or regulatory status.

For pharmaceutical manufacturers and analytical laboratories, important considerations include:

1. Risk assessment: Evaluate relevant manufacturing processes, raw materials, formulation components, and storage conditions for potential sources of nitrosamine impurities.

2. Confirmatory testing: Where indicated by the risk assessment, use a suitably sensitive and specific analytical method.

3. Method validation: Establish that the method is appropriate for the particular matrix, analyte, concentration range, and intended use.

4. Documentation: Maintain suitable records of analytical procedures, reference-material identity, results, and relevant quality decisions.

5. Ongoing review: Consult current guidance applicable to the product and target market as scientific understanding and regulatory recommendations evolve.

The FDA notes that its recommended approaches and limits are updated as new evidence becomes available. Its published methods may also require validation by the user when the resulting data support a quality assessment or regulatory submission.

Accordingly, laboratories should consult the latest applicable guidance rather than applying limits or classifications from a different nitrosamine without scientific justification.

7. Selecting a Suitable Supplier for Pharmaceutical Impurity Standards

Choosing an impurity reference material involves more than comparing product names and prices. Researchers and procurement teams should assess whether the material's identity and documentation meet their intended requirements.

Useful evaluation criteria include:

• Clear product identification and a unique catalogue number.

• Available molecular formula, molecular weight, and structural information.

• A certificate of analysis describing the tests performed and their results.

• Relevant characterization data, such as LC-MS and NMR, where available.

• Clearly stated purity results and the method used to determine them.

• Appropriate handling, storage, and research-use information.

• Supplier communication regarding availability and any additional documentation requirements.

For specialized compounds, it is also prudent to confirm current stock status, quantity options, lead time, and the availability of supporting documentation before placing an order.

Chemicea Pharmaceuticals Pvt. Ltd., headquartered in Navi Mumbai, India, offers pharmaceutical impurity reference standards alongside custom synthesis and analytical solutions. Its product information for N-Nitroso Alprazolam EP Impurity H identifies the material as CP-A14018 and provides the reported characterization details discussed above. Availability and documentation should be confirmed directly with the company.

Conclusion

N-Nitroso Alprazolam EP Impurity H is a specialized compound relevant to pharmaceutical impurity characterization and analytical research. Reliable evaluation begins with confirming its chemical identity and distinguishing it from similarly named compounds, particularly Alprazolam EP Impurity H, which has a different molecular formula and molecular weight.

LC-MS, proton NMR, and HPLC can contribute complementary information about identity and chromatographic purity. However, the interpretation of these results depends on the analytical method, available documentation, and intended application. Reference materials can support method development and impurity investigations, but their suitability must be assessed for the specific laboratory and quality requirements.

For researchers, QC teams, and pharmaceutical procurement professionals, selecting a well-documented impurity standard is an important step toward reliable analytical work. Chemicea's product documentation for CP-A14018 provides a starting point for evaluating this material, while additional qualification and testing decisions should be based on the laboratory's needs and applicable regulatory guidance.

Ultimately, accurate identification, appropriate analytical characterization, and evidence-based risk assessment are central to effective pharmaceutical impurity research.